Longer TOMM40 poly-T variants associated with higher FDDNP-PET medial temporal tau and amyloid binding. by Prabha Siddarth, Alison C Burggren, David A Merrill, Linda M Ercoli, Zanjbeel Mahmood, Jorge R Barrio, Gary W Small

Get full text

Alzheimer’s Amyloid Hypothesis and Antibody Therapy: Melting Glaciers? by Poul F. Høilund-Carlsen, Abass Alavi, Rudolph J. Castellani, Rachael L. Neve, George Perry, Mona-Elisabeth Revheim, Jorge R. Barrio

Get full text

FDG-PET versus Amyloid-PET Imaging for Diagnosis and Response Evaluation in Alzheimer’s Disease: Benefits and Pitfalls by Poul F. Høilund-Carlsen, Mona-Elisabeth Revheim, Tommaso Costa, Kasper P. Kepp, Rudolph J. Castellani, George Perry, Abass Alavi, Jorge R. Barrio

Get full text

Towards a pharmacophore for amyloid. by Meytal Landau, Michael R Sawaya, Kym F Faull, Arthur Laganowsky, Lin Jiang, Stuart A Sievers, Jie Liu, Jorge R Barrio, David Eisenberg

Get full text

Automated movement correction for dynamic PET/CT images: evaluation with phantom and patient data. by Hu Ye, Koon-Pong Wong, Mirwais Wardak, Magnus Dahlbom, Vladimir Kepe, Jorge R Barrio, Linda D Nelson, Gary W Small, Sung-Cheng Huang

Get full text

[F-18]FDDNP microPET imaging correlates with brain Aβ burden in a transgenic rat model of Alzheimer disease: Effects of aging, in vivo blockade, and anti-Aβ antibody treatment by Edmond Teng, Vladimir Kepe, Sally A. Frautschy, Jie Liu, Nagichettiar Satyamurthy, Fusheng Yang, Ping-Ping Chen, Graham B. Cole, Mychica R. Jones, Sung-Cheng Huang, Dorothy G. Flood, Stephen P. Trusko, Gary W. Small, Gregory M. Cole, Jorge R. Barrio

Get full text